Fig. 4From: The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patientsWT1 expression levels. The WT1 expression levels significantly impacted on survival: the 12-months OS was 83% for cases with low levels after induction versus 29% for those with high WT1 expression levels (p = 0.008) (a), and EFS was 0% for cases with high versus 61% for those with low WT1 expression (p < 0.001) (b)Back to article page